| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA1341231C Primary biliary cirrhosis autoantigen |
| 05/15/2001 | CA1341227C Human transforming growth factor alpha |
| 05/10/2001 | WO2001033573A1 Method of analysing cell samples, by creating and analysing a resultant image |
| 05/10/2001 | WO2001033243A1 Use of double-quantum 1h-nmr spectroscopy for the identification of ligands interacting with target biomolecules |
| 05/10/2001 | WO2001033230A2 Biological sample component purification and differential display |
| 05/10/2001 | WO2001033229A1 Method for the detection of mammalian carcinomas |
| 05/10/2001 | WO2001033228A2 Cancer diagnosis employing cell-sorting and gene-profiles |
| 05/10/2001 | WO2001033226A1 Cantilever sensors and transducers |
| 05/10/2001 | WO2001033225A2 B-cell superantigen mediated antibody-ligand dissociation |
| 05/10/2001 | WO2001033224A1 Composite particles, derived conjugates and their conjugates with biomolecules |
| 05/10/2001 | WO2001033223A1 Composite nanospheres and their conjugates with biomolecules |
| 05/10/2001 | WO2001033222A1 Personal pregnancy testing kit |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001033220A2 The use of the area postreama to identify therapeutic compounds |
| 05/10/2001 | WO2001033219A2 Ion channel permeability |
| 05/10/2001 | WO2001033218A1 Method for identifying active anti-apoptosis compounds |
| 05/10/2001 | WO2001033217A2 Monitoring the activity of factor xa inhibitors |
| 05/10/2001 | WO2001033216A1 Small volume in vitro analyte sensor and related methods |
| 05/10/2001 | WO2001033215A1 System and method for generating a profile of particulate components of a body fluid sample |
| 05/10/2001 | WO2001033214A2 Test element analysis system with an infrared detector |
| 05/10/2001 | WO2001033213A2 Carbon monoxide emitting apparatus, carbon monoxide monitor shutoff, and circuit therefor |
| 05/10/2001 | WO2001033212A2 Method and computer code for portable sensing |
| 05/10/2001 | WO2001033211A1 An apparatus for high-throughput production of coat material arrays, and analytical methods using such arrays |
| 05/10/2001 | WO2001033207A1 Microscopic multi-site sensor array with integrated control and analysis circuitry |
| 05/10/2001 | WO2001033206A1 Microscopic combination amperometric and potentiometric sensor |
| 05/10/2001 | WO2001033205A1 Semiconductor gas sensors |
| 05/10/2001 | WO2001033199A2 Universal fluorescent sensors |
| 05/10/2001 | WO2001033198A1 Test method and apparatus for assessing a tendency to squeak |
| 05/10/2001 | WO2001033197A1 Method for verifying that a specific stain was used on a cytological sample |
| 05/10/2001 | WO2001033195A1 Method and apparatus for detection of a bubble in a liquid |
| 05/10/2001 | WO2001033194A1 Method and device for in situ triaxial test |
| 05/10/2001 | WO2001033192A1 Cytological stain composition |
| 05/10/2001 | WO2001033191A1 Cytological imaging system and method |
| 05/10/2001 | WO2001033190A2 Automated laser capture microdissection |
| 05/10/2001 | WO2001033188A2 Assay method for determining product r's effect on adenovirus infection of hela cells |
| 05/10/2001 | WO2001033173A1 Device and method for measuring fluid and solute fluxes in flow systems |
| 05/10/2001 | WO2001033042A1 Foam monitoring and control system |
| 05/10/2001 | WO2001032935A2 Molecular microarrays and methods for production and use thereof |
| 05/10/2001 | WO2001032930A1 Methods and apparatuses for analyzing polynucleotide sequences |
| 05/10/2001 | WO2001032928A2 Methods of determining individual hypersensitivity to an agent |
| 05/10/2001 | WO2001032927A2 Tissue specific genes of diagnostic import |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032925A1 Modulation of neuroendocrine differentiation by protein 25.1 |
| 05/10/2001 | WO2001032920A2 Agents implicated in endometriosis |
| 05/10/2001 | WO2001032914A1 Method of analysing cell samples, by creating and analysing a resultant image |
| 05/10/2001 | WO2001032913A1 Method of analysing cell samples, by creating and analysing a resultant image |
| 05/10/2001 | WO2001032912A1 Use of the jak-stat system in cultured cells to trace effects of tested compounds |
| 05/10/2001 | WO2001032908A1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032877A2 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032831A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 05/10/2001 | WO2001032828A2 Biological fluid processing |
| 05/10/2001 | WO2001032802A1 Method and apparatus for predicting male infertility |
| 05/10/2001 | WO2001032783A1 Water-soluble rhodamine dyes and conjugates thereof |
| 05/10/2001 | WO2001032710A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | WO2001032705A1 Ghsr ligand polypeptides and dnas thereof |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032694A2 Method for characterising and separating molecular associates |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |
| 05/10/2001 | WO2001032673A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | WO2001032320A1 An improved combinatorial testing method and apparatus for coat material formulations and methods |
| 05/10/2001 | WO2001032303A1 Batch fabrication of electrodes |
| 05/10/2001 | WO2001032290A1 Physiological fluid separation vehicles having improved resistance to inward migration of therapeutic agents |
| 05/10/2001 | WO2001032209A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/10/2001 | WO2001032186A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 05/10/2001 | WO2001032184A2 Abc1 modulation for the modulation of cholesterol transport |
| 05/10/2001 | WO2001032161A2 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 05/10/2001 | WO2001032156A2 Methods for treating fibroproliferative diseases |
| 05/10/2001 | WO2001032070A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/10/2001 | WO2001032022A1 YtgP |
| 05/10/2001 | WO2001032015A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 05/10/2001 | WO2001031989A2 High throughput screening (hts) assays for protein variants with reduced antibody binding capacity |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001016304A3 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/10/2001 | WO2001006248A3 Biosensors for monitoring air conditioning and refrigeration processes |
| 05/10/2001 | WO2001005824A3 Synthetic peptides immunoreactive with hepatitis a virus antibodies |
| 05/10/2001 | WO2001000869A3 Arrays of catalytic or pre-catalytic nucleic acids |
| 05/10/2001 | WO2000077243A3 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000072666A3 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 05/10/2001 | WO2000061802A3 Method and kitset for sampling and storage of biological samples |
| 05/10/2001 | WO2000061067B1 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 05/10/2001 | WO2000045702A8 Automatic lung parameter estimator |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | WO2000032824A3 Length determination of nucleic acid repeat sequences by discontinuous primer extension |
| 05/10/2001 | US20010001131 Bar code gasoline blending |
| 05/10/2001 | US20010001062 Screening methods for presqualene diphosphate analogs |
| 05/10/2001 | US20010001061 Assay for disease related conformation of a protein |
| 05/10/2001 | US20010001060 Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system |
| 05/10/2001 | US20010001059 Locating single milk duct, introducing washing fluid throughout duct without rupture, collecting at least a portion of the washing fluid from the duct and identifying materials in the washing fluid; breast cancer detection |
| 05/10/2001 | US20010001058 Method for identifying substance capable of disrupting interaction between herpes simplex virus ICP34.5 polypeptide or homologue thereof, or derivative thereof, and proliferating cell nuclear antigen or a homologue thereof; viricides |
| 05/10/2001 | US20010001038 A free-flowing suspension of activated carbon particles ground and graded to <50 mu; antiagglomerants; grinding in a cylindrical rod mill in a chamber coated with a nonabrasive lining; accuracy |
| 05/10/2001 | US20010001034 Comprising a hollow fiber capillary tube having a matrix for receiving fluid sample, an indicating reagent for reacting with analyte and a housing postioned for receiving light and directing it from the tube to a light detector |